UltraVision CLPL completes Global Licensing Agreement with Bausch + Lomb

Jan. 28, 2011 - PRLog -- Bausch + Lomb announced today a global licensing agreement to market KeraSoft® contact lenses throughout the world. See below to read the Bausch + Lomb Press Release. The financial terms of this deal remain confidential but with Bausch + Lomb now behind KeraSoft both companies expect the lenses will give sight back to literally millions of people around the world.

J Keith Lomas, Group CEO of UltraVision CLPL, said “We’re delighted with this transformational deal. We’ve developed life-changing KeraSoft technology in the UK and Bausch + Lomb, a clear market leader, will now use its brand and channels to take it global. We will continue with our core focus on developing and licensing innovative technologies”.

Headquartered in Rochester, New York, USA, Bausch + Lomb has ~11,000 employees and products available in more than 100 countries.

About Bausch + Lomb
Bausch + Lomb is one of the best-known and most respected healthcare companies in the world. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.

Please click the link to read the Bausch + Lomb Press Release http://www.bausch.com/en_US/corporate/corpcomm/news/licen...

# # #

A world class innovative contact lens manufacturer, supplying a wide range of Silicone Hydrogel, soft disposable, durable & GP contact lenses using the latest in lathe cutting systems & licensing patented technologies to 3rd party manufacturers worldwide.